يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Fanny Lemée"', وقت الاستعلام: 0.83s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Circulating CD14high CD16low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression

    المؤلفون: Mélissa Prat, Augustin Le Naour, Kimberley Coulson, Fanny Lemée, Godefroy Jacquemin, Mouna Chirine Rahabi, Léa Lemaitre, Jean-Marc Barret, Maha Ayyoub, Jean-Pierre Delord, Isabelle Tabah-Fisch, Jean-François Prost, Bettina Couderc

    المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://jitc.bmj.com/content/8/1/e000472.full; https://doaj.org/toc/2051-1426

    URL الوصول: https://doaj.org/article/0b2540fb3f554340aaa02a1869f2470b

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell Activation

    المؤلفون: Mélissa Prat, Marie Salon, Thibault Allain, Olivier Dubreuil, Grégory Noël, Laurence Preisser, Bérangère Jean, Lydie Cassard, Fanny Lemée, Isabelle Tabah-Fish, Bernard Pipy, Pascale Jeannin, Jean-François Prost, Jean-Marc Barret, Agnès Coste

    المصدر: Cancers, Vol 13, Iss 8, p 1845 (2021)

    مصطلحات موضوعية: murlentamab, glyco-engineered antibody, tumor-associated macrophages, ovarian cancer, adaptive immunity, immunotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://www.mdpi.com/2072-6694/13/8/1845; https://doaj.org/toc/2072-6694

    URL الوصول: https://doaj.org/article/5522b2340f504a75be168a55f75881b5

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  3. 3
    Circulating CD14high CD16low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression

    المؤلفون: Godefroy Jacquemin, Bettina Couderc, Augustin Le Naour, Gwenael Ferron, Kimberley Coulson, Jean-Marc Barret, Hélène Leray, Hélène Authier, Maha Ayyoub, Jean-Pierre Delord, Lea Lemaitre, Isabelle Tabah-Fisch, Jean-François Prost, Mouna Rahabi, Alejandra Martinez, Agnès Coste, Mélissa Prat, Fanny Lemée, Laurence Gladieff

    المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
    Journal for Immunotherapy of Cancer

    مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Immunology, Short Report, Lipopolysaccharide Receptors, Monocytes, Immune system, biomarkers, tumor, Internal medicine, Ascites, medicine, Tumor Microenvironment, Immunology and Allergy, Humans, RC254-282, Pharmacology, Tumor microenvironment, business.industry, Receptors, IgG, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunosuppression, Immunotherapy, medicine.disease, immunity, macrophages, Tumor progression, Disease Progression, Molecular Medicine, Biomarker (medicine), Female, medicine.symptom, business, Ovarian cancer

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93b99c566fc73079451fd3c8d667b334
    https://jitc.bmj.com/content/8/1/e000472.full

    Find this article in full text from ProQuest
    أضف إلى المفضلة
  4. 4
    First-in-human first-in-class phase I trial of murlentamab, an anti-Mullerian-hormone receptor II (AMHRII) monoclonal antibody acting through tumor-associated macrophage (TAM) engagement, as single agent and in combination with carboplatin (C) and paclitaxel (P) in AMHRII-expressing advanced/metastatic gynecological cancer patients (pts)

    المؤلفون: François-Xavier Frenois, Christophe Le Tourneau, Ignace Vergote, Ahmad Awada, Jean-Pierre Delord, Marine Villard, Anne Floquet, Fanny Lemée, Elsa Kalbacher, Agnès Coste, Cyril Abdeddaim, Isabelle Tabah-Fisch, Alexandra Leary, Lydie Cassard, Olivier Lantz, Susana Banerjee, Isabelle Ray-Coquard, Michel Fabbro, Grégory Noël

    المساهمون: Pharmacochimie et Biologie pour le Développement (PHARMA-DEV), Institut de Recherche pour le Développement (IRD)-Institut de Chimie de Toulouse (ICT), Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie de Toulouse (ICT-FR 2599), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Institut de Chimie du CNRS (INC)-Institut de Recherche pour le Développement (IRD)

    المصدر: Journal of Clinical Oncology
    Journal of Clinical Oncology, 2019, 37 (15_suppl), pp.2521-2521. ⟨10.1200/JCO.2019.37.15_suppl.2521⟩
    Journal of Clinical Oncology, American Society of Clinical Oncology, 2019, 37 (15_suppl), pp.2521-2521. ⟨10.1200/JCO.2019.37.15_suppl.2521⟩

    مصطلحات موضوعية: Cancer Research, medicine.drug_class, business.industry, macrophage (TAM), paclitaxel (P), [SDV]Life Sciences [q-bio], Tumor-associated macrophage, CD16, Monoclonal antibody, Carboplatin, 3. Good health, Cell membrane, chemistry.chemical_compound, medicine.anatomical_structure, Oncology, chemistry, Paclitaxel, anti-Mullerian-hormone receptor II (AMHRII), Anti-Müllerian hormone receptor, Cancer research, medicine, Macrophage, carboplatin (C), business, AMHRII-expressing advanced/metastatic gynecological cancer patients

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ad29e1b03c6e5c3ba3a3d420bd573ac
    https://doi.org/10.1200/jco.2019.37.15_suppl.2521

    أضف إلى المفضلة
  5. 5
    Abstract 774: Anti-Müllerian hormone type II receptor (AMHRII) found expressed in human non-gynecological solid tumors, suggesting potential broader applications for anti-AMHRII-based therapy

    المؤلفون: André Nicolas, Isabelle Ray-Coquard, Gabriel Champenois, Jean-François Prost, Céline Bossard, Solenne Gaillard, Didier Meseure, Mikko Anttonen, Isabelle Tabah-Fisch, Emily Loison, Alexandra Leary, Emeline Perrial, Anne Jarry, Anniina Färkkilä, Noora Andersson, Aurélie Auguste, Guillaume Bataillon, Olivier Dubreuil, Fanny Lemée, Jean-Marc Barret, Charles Dumontet, Mehdi Lahmar, Anne Vincent-Salomon

    المصدر: Cancer Research. 78:774-774

    مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Tissue microarray, biology, Colorectal cancer, business.industry, Melanoma, Cancer, medicine.disease, 3. Good health, Lymphoma, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Cancer cell, medicine, Cancer research, biology.protein, Immunohistochemistry, Antibody, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3255316384ce250b2eb38a1bc8e53adb
    https://doi.org/10.1158/1538-7445.am2018-774

    أضف إلى المفضلة
  6. 6
    DNA polymeraseθ up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability

    المؤلفون: Catherine Gentil, Bernd Kaina, Naïma Oumouhou, Valérie Bergoglio, Lee Baker, Anne Fernandez-Vidal, Eddy Magdeleine, Magali Lacroix-Triki, Henri Roché, Elena Lam, Alice Machado-Silva, Richard D. Wood, Marie Jeanne Pillaire, Christophe Cazaux, Anne Laure Martin, Claire Leduc, Mineaki Seki, Thomas Filleron, Anne Bieth, Jean Sébastien Hoffmann, Fanny Lemée, Jean-Christophe Bourdon, Fanny Grimal, Alastair M. Thompson

    المساهمون: Institut de pharmacologie et de biologie structurale (IPBS), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS), Service d'épidémiologie [Toulouse], CHU Toulouse [Toulouse], Université Fédérale Toulouse Midi-Pyrénées, Institut Claudius Regaud, CRLCC Institut Claudius Regaud, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées

    المصدر: Proceedings of the National Academy of Sciences of the United States of America
    Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2010, 107 (30), pp.13390-13395. ⟨10.1073/pnas.0910759107⟩

    مصطلحات موضوعية: DNA Replication, Genome instability, DNA damage, DNA polymerase, [SDV]Life Sciences [q-bio], DNA Polymerase Theta, Breast Neoplasms, DNA-Directed DNA Polymerase, Kaplan-Meier Estimate, medicine.disease_cause, Bioinformatics, Genomic Instability, Cell Line, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Cell Line, Tumor, Chromosome instability, Cyclin E, medicine, Humans, ComputingMilieux_MISCELLANEOUS, 030304 developmental biology, 0303 health sciences, Multidisciplinary, biology, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Cancer, Middle Aged, Biological Sciences, Prognosis, medicine.disease, United Kingdom, Up-Regulation, Gene Expression Regulation, Neoplastic, 030220 oncology & carcinogenesis, Cancer research, biology.protein, Female, RNA Interference, France, Carcinogenesis, DNA Damage

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff795f5151d97b2110d423da855ead41
    https://doi.org/10.1073/pnas.0910759107

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء